Advances in nano research

  • 제5권1호
  • /
  • Pages.49-59
  • /
  • 2017
  • /
  • 2287-237X(pISSN)
  • /
  • 2287-2388(eISSN)
테크노프레스 (Techno-Press)
권호 표지
DOI QR코드

DOI QR Code

An overview on recent new nano-anti-parasitological findings and application

  • Farhoudi, Ramin (Department of Laboratory Animal Science, Pasteur Institute of Iran)
  • 투고 : 2016.07.13
  • 심사 : 2016.11.24
  • 발행 : 2017.03.25
⟨ 이전 논문 다음 논문 ⟩

초록

Till now nanotechnology based anti-parasite pharmaceutical dosage forms development and application is being vastly developed worldwide. The field of nanotechnology involves an array of different areas of expertise with the application of innovative products in Medicine, Engineering, and to a less extent to Veterinary Medicine. In our conclusion, enriched experimental analysis is required, to announce the state of the art outputs to remove negative problems. Animals or human may benefit from nanotechnological products respectively, like vaccines, target recombinant peptides, or novel pharmaceutical alternatives. As a result, it would be desirable to give some energy for thought to drive nanomedical scientific introductions. To create more safe medium to animals and or humans. In this review all aspects of nanoparticles applications in parasitology will be carefully discussed depending on particle charge and size as well as kind of nanoparticles. Perspectives and prospective of nanoparticles in human parasitology will be predicted as well.

키워드

참고문헌

  1. Agrawal, S.K., Sanabria-DeLong, N., Coburn, J.M., Tew, G.N. and Bathia, S.R. (2006), "Novel drug release profiles from micellar solutions of PLAPEOPLA triblock copolymers", J. Control. Release, 112(1), 64-71. https://doi.org/10.1016/j.jconrel.2005.12.024
  2. Agueros, M., Ruiz-Gaton, L., Vauthier, C., Bouchemal, K., Espuelas, S., Ponchel, G. and Irache, J.M. (2015), "Combined hydroxypropyl-${\beta}$-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel", Eur. J. Pharm. Sci., 38(4), 405-413. https://doi.org/10.1016/j.ejps.2009.09.010
  3. Agueros, M., Zabaleta, V., Espuelas, S., Campanero, M.A. and Irache, J.M. (2010), "Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles", J. Control. Release, 145(1), 2-8. https://doi.org/10.1016/j.jconrel.2010.03.012
  4. Alam, S., Pandai, J.J., Mukherjee, T.K. and Chauhan, V.S. (2016), "Short peptide based nanotubes capable of effective curcumin delivery for treating drug resistant malaria", J. Nanobiotechnol., 14, 26. DOI: 10.1186/s12951-016-0179-8
  5. Allahverdiyev, A.M., Bagirova, M., Abamor, E.S., Ates, S.C., Koc, R.C., Miraloglu, M., Elcicek, S., Yaman, S. and Unal, G. (2013), "The use of platensimycin and platencin to fight antibiotic resistance", Infect. Drug Resist., 6, 99-114.
  6. Allemann, E., Gurnay, R. and Doelker, E. (1992), "Preparation of aqueous polymeric nanodispersions by a reversible salting-out process, influence of process parameters on particle size", Int. J. Pharm., 87(1-3), 247-253. https://doi.org/10.1016/0378-5173(92)90249-2
  7. Allison, A.C. and Gregoriadis, G. (1974), "Liposomes as immunological adjuvants", Nature, 252, 252.
  8. Ambruosi, A., Yamamoto, H. and Kreuter, J. (2005), "Body distribution of polysorbate-80 and doxorubicinloaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats", J. Drug Target., 13, 535-542. https://doi.org/10.1080/10611860500411043
  9. Arangoa, M.A., Campanero, M.A., Renedo, M.J., Ponchel, G. and Irache, J.M. (2001), "Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationship between bioadhesion and pharmacokinetics", Pharm. Res., 18(11), 1521-1527. https://doi.org/10.1023/A:1013018111829
  10. Berton, M., Turelli, P., Trono, D., Stein, C.A., Allemann, E. and Gurny, R. (2001), "Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles", Pharm. Res., 18(8), 1096-1101. https://doi.org/10.1023/A:1010962507273
  11. Bhushan, B. (2010), "Nanomechanical characterization of skin and skin cream", J. Microscopy, 240(2), 135-144. https://doi.org/10.1111/j.1365-2818.2010.03407.x
  12. Bielinska, A.U., Kukowska-Latallo, J.F., Johnson, J., Tomalia, D.A. and Baker, J.R. (1996), "Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers", Nucleic Acids Res., 24(11), 2176-2182. https://doi.org/10.1093/nar/24.11.2176
  13. Birrenbach, G. (1973), "Uber Mizellpolymerisate, mogliche Einschlussverbindungen (Nanokapseln) und deren Eignung als Adjuvantien", Ph.D. Thesis, Dissertation; ETH Nr. 5071.
  14. Birrenbach, G. and Speiser, P.P. (1976), "Polymerized micelles and their use as adjuvants in immunology", J. Pharm. Sci., 65(12), 1763-1766. https://doi.org/10.1002/jps.2600651217
  15. Bivas-Benita, M., Lin, M.Y., Bal, S.M., van Meijgaarden, K.E., Franken, K.L., Friggen, A.H., Junginger, H.E., Borchard, G., Klein, M.R. and Ottenhoff, T.H. (2009), "Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice", Vaccine, 27(30), 4010-4017. https://doi.org/10.1016/j.vaccine.2009.04.033
  16. Bivas-Benita, M., Laloup, M., Versteyhe, S., Dewit, J., De, B.J., Jongert, E. and Borchard, G. (2003), "Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies", Int. J. Pharm., 266(1-2), 17-27. https://doi.org/10.1016/S0378-5173(03)00377-6
  17. Borges, O., Tavares, J., de Sousa, A., Borchard, G., Junginger, H.E. and Cordeiroda-Silva, A. (2007), "Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles", Eur. J. Pharm. Sci., 32(4-5), 278-290. https://doi.org/10.1016/j.ejps.2007.08.005
  18. Bottomley, K. (2006), "Nanotechnology for drug delivery: A validated technology?", Drug Deliv. Rep. (Autumn/Winter), 20-21.
  19. Boudad, H., Legrand, P., Appel, M., Coconier, M.H. and Ponchel, G. (2001), "Formulation and cytotoxicity of combined cyclodextrin poly(alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir", STP Pharm. Sci., 11(5), 369-375.
  20. Bowman, K. and Leong, K.W. (2006), "Chitosan nanoparticles for oral drug and gene delivery", Int. J. Nanomed., 1(2), 117-128. https://doi.org/10.2147/nano.2006.1.2.117
  21. Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S. and Saettone, M.F. (2002), "Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin", Int. J. Pharm., 238(1-2), 241-245. https://doi.org/10.1016/S0378-5173(02)00080-7
  22. Chen, S.C., Jones, D.H., Fynan, E.F., Farrar, G.H., Clegg, J.C., Greenberg, H.E. and Herrmann, J.E. (1998), "Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles", J. Virol., 72(7), 5757-5761.
  23. Cheng, Y. and Xu, T. (2005), "Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers", Eur. J. Med. Chem., 40(11), 1188-1192. https://doi.org/10.1016/j.ejmech.2005.06.010
  24. Chiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J.P. and Couvreur, P. (1990), "Hepatic tissue distribution of doxorubicin loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice", Cancer Chemother. Pharmacol., 26(2), 122-126. https://doi.org/10.1007/BF02897257
  25. Conway, M.A., Madrigal-Estebas, L., McClean, S., Brayden, D.J. and Mills, K.H. (2001), "Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: Effect of formulation and route of immunization on induction of Th1 and Th2 cells", Vaccine, 19(15-16), 1940-1950. https://doi.org/10.1016/S0264-410X(00)00433-3
  26. Cossart, P. (2004), "Bacterial invasion: A new strategy to dominate cytoskeleton plasticity", Dev. Cell, 6(3), 314-315. https://doi.org/10.1016/S1534-5807(04)00072-3
  27. Couvreur, P., Kante, B., Roland, M., Guiot, P., Baudin, P. and Speiser, P. (1979), "Polycyanoacrylate nanocapsules as potential lysosomotropic carriers-preparation, morphological and sorptive properties", J. Pharm. Pharmacol., 31(1), 331-332. https://doi.org/10.1111/j.2042-7158.1979.tb13510.x
  28. Couvreur, P. and Puisieux, F. (1993), "Nano-and micro-particles for the delivery of polypeptides and proteins", Adv. Drug Deliv. Rev., 10(2-3), 141-162. https://doi.org/10.1016/0169-409X(93)90046-7
  29. Couvreur, P., Barratt, G., Fattal, E. Legrand, P. and Vauthier, C. (2002), "Nanocapsule technology: A review", Crit. Rev. Ther. Drug Carrier Syst., 19(2), 99-134. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v19.i2.10
  30. Couvreur, P., Gref, R., Andrieux, K. and Malvy, C. (2006), "Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases", Prog. Solid State Chem., 34(2-4), 231-235. https://doi.org/10.1016/j.progsolidstchem.2005.11.009
  31. Couvreur, P. and Vauthier, C. (2006), "Nanotechnology: Intelligent design to treat complex disease", Pharm. Res., 23(7), 1417-1450. https://doi.org/10.1007/s11095-006-0284-8
  32. Cronkhite, R.I. and Michael, J.G. (2004), "Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties", Vaccine, 22(17-18), 2106-2115. https://doi.org/10.1016/j.vaccine.2003.12.012
  33. Croy, S.R. and Kwon, G.S. (2006), "Preparation of small-sized particles from vicilin (vegetal protein from Pisum sativum L.) by coacervation", Eur. J. Pharm. Biopharm., 42(1), 36-41.
  34. D'Emanuele, A. and Attwood, D. (2005), "Dendrimer-drug interactions", Adv. Drug Deliv. Rev., 57(15), 2147-2162. https://doi.org/10.1016/j.addr.2005.09.012
  35. Ekman, P. and Friesen, W.V. (1976), Pictures of Facial Affect, Consulting Psychologists, Palo Alto, CA, USA.
  36. Ezpeleta, I., Irache, J.M., Stainmesse, S., Chabenat, C., Gueguen, J., Popineau, Y. and Orecchioni, A.M. (1996b), "Gliadin nanoparticles for the controlled release of all-trans retinoic acid", Int. J. Pharm., 131(2), 191-200. https://doi.org/10.1016/0378-5173(95)04338-1
  37. Fattal, E., Youssef, M., Couvreur, P. and Andremont, A. (1989), "Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles", Antimicrob. Agents Chemother., 33(9), 1540-1543. https://doi.org/10.1128/AAC.33.9.1540
  38. Fattal, E. and Vauthier, C. (2002), "Nanoparticles as drug delivery systems", In: Encyclopedia of Pharmaceutical Technology, (J. Swarbrick, J.C. Boylan Eds.), Marcel Dekker, New York, NY, USA, pp. 1864-1882.
  39. Fernandez, L., Gonzalez, M., Cerecetto, H., Santo, M. and Silber, J.J. (2006), "Solubilization and release properties of dendrimers. Evaluation as prospective drug delivery systems", Supramol. Chem., 18(8), 633-643. https://doi.org/10.1080/10610270601012776
  40. Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N. and Benita, S. (1989), "Nanocapsule formation by interfacial deposition following solvent displacement", Int. J. Pharm., 55(1), R1-R4. https://doi.org/10.1016/0378-5173(89)90281-0
  41. Florence, A.T., Hillery, A.M., Hussain, N. and Jani, P.U. (1995), "Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate", J. Control. Release, 36(1-2), 39-46. https://doi.org/10.1016/0168-3659(95)00059-H
  42. Florindo, H.F., Pandit, S., Lacerda, L., Goncalves, L.M.D., Alpar, H.O. and Almeida, A.J. (2009), "The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles", Biomaterials, 30(5), 879-891. https://doi.org/10.1016/j.biomaterials.2008.10.035
  43. Foger, F., Noonpakdee, W., Loretz, B., Joojuntr, S., Salvenmoser, W., Thaler, M. and Bernkop-Schnurch, A. (2006), "Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles", Int. J. Pharm., 319(1-2), 139-146. https://doi.org/10.1016/j.ijpharm.2006.03.034
  44. Fouarge, M., Dewulf, M., Couvreur, P., Rolland, M. and Vranckx, H. (1989), "Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis", J. Microencapsul., 6(1), 29-34. https://doi.org/10.3109/02652048909019899
  45. Frechet, J.M.J. (1994), "Functional polymers and dendrimers: Reactivity, molecular architecture, and interfacial energy", Science, 263(5154), 1710-1715. https://doi.org/10.1126/science.8134834
  46. Fresta, M., Fontana, G., Bucolo, C., Cavallo, G., Giammona, G. and Puglisi, G. (2001), "Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphereencapsulated acyclovir", J. Pharm. Sci., 90(3), 288-297. https://doi.org/10.1002/1520-6017(200103)90:3<288::AID-JPS4>3.0.CO;2-5
  47. Gbadamosi, J.K., Hunter, A.C. and Moghimi, S.M. (2002), "PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance", FEBS Lett., 532(3), 338-344. https://doi.org/10.1016/S0014-5793(02)03710-9
  48. Gomez, S., Gamazo, C., San Roman, B., Vauthier, C., Ferrer, M. and Irache, J.M. (2006), "Development of a novel vaccine delivery system based on Gantrez nanoparticles", J. Nanosci. Nanotechnol., 6(9-10), 3283-3289. https://doi.org/10.1166/jnn.2006.471
  49. Gomez, S., Gamazo, C., San Roman, B., Ferrer, M., Sanz, M.L., Espuelas, S. and Irache, J.M. (2008), "Allergen immunotherapy with nanoparticles containing lypopolysaccharide from Brucella ovis", Eur. J. Pharm. Biopharm., 70(3), 711-717. https://doi.org/10.1016/j.ejpb.2008.05.016
  50. Gomez, S., Gamazo, C., San Roman, B., Grau, A., Espuelas, S., Ferrer, M., Sanz, M.L. and Irache, J.M. (2009), "A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne", J. Immunol. Methods, 348(1-2), 1-8. https://doi.org/10.1016/j.jim.2009.06.005
  51. Gradishar, W.J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M. and O'Shaughnessy, J. (2005), "Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer", J. Clin. Oncol., 23(31), 7794-7803. https://doi.org/10.1200/JCO.2005.04.937
  52. Greco, F. and Vicent, M.J. (2009), "Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines", Adv. Drug Deliv. Rev., 61(13), 1203-1213. https://doi.org/10.1016/j.addr.2009.05.006
  53. Green, M.R., Manikhas, G.M., Orlov, S., Afanasyev, B., Makhson, A.M., Bhar, P. and Hawkins, M.J. (2006), "Abraxane, a novel cremophor-free, albuminbound particle form of paclitaxel for the treatment of advanced nonsmall-cell lung cancer", Ann. Oncol., 17(8), 1263-1268. https://doi.org/10.1093/annonc/mdl104
  54. Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V. and Langer, R. (1994), "Biodegradable long-circulating polymeric nanospheres", Science, 263(5153), 1600-1603. https://doi.org/10.1126/science.8128245
  55. Gregoriadis, G. and Ryman, B.E. (1972), "Lysosomal localization of ${\beta}$-fructofuranosidase-containing liposomes injected into rats. Some implications in the treatment of genetic disorders", Biomech. J., 129(1), 123-133.
  56. Gurny, R., Peppas, N.A., Harrington, D.D. and Banker, G.S. (1981), "Development of biodegradable and injectable lattices for controlled release of potent drugs", Drug Dev. Ind. Pharm., 7(1), 1-25. https://doi.org/10.3109/03639048109055684
  57. Huynh, N.T., Passirani, C., Saulnier, P. and Benoit, J.P. (2009), "Lipid nanocapsules: A new platform for nanomedicine", Int. J. Pharm., 379(2), 201-209. https://doi.org/10.1016/j.ijpharm.2009.04.026
  58. Joe, Y.H., Park, D.H. and Hwang, J. (2016), "Evaluation of Ag nanoparticle coated air filter against aerosolized virus: Anti-viral efficiency with dust loading", J. Hazard Mater., 301, 547-553. https://doi.org/10.1016/j.jhazmat.2015.09.017
  59. Jung, G., Brandl, M., Eisner, W., Fraunberger, P., Reifenberger, G., Schlegel, U., Wiestler, O.D., Reulen, H.J. and Wilmanns, W. (2001), "Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: Evidence for in situ t-cell activation and therapeutic efficacy", Int. J. Cancer, 91(2), 225-230. https://doi.org/10.1002/1097-0215(200002)9999:9999<::AID-IJC1038>3.3.CO;2-7
  60. Klajnert, B. and Bryszewska, M. (2001), "Dendrimers: Properties and applications", Acta Biochemica Polonica, 48(1), 199-208.
  61. Kreuter, J. (1978), Book Chapter: New Generation Vaccines; Volume 261 of the series NATO ASI Series, Nanoparticles as Potent Adjuvants for Vaccines, pp. 73-81.
  62. Kumari, A., Yadav, S.K. and Yadav, S.C. (2010), "Biodegradable polymeric nanoparticles based drug delivery systems", Colloid Surf. B: Biointerf., 75(1), 1-18. https://doi.org/10.1016/j.colsurfb.2009.09.001
  63. Kwon, G.S. (2003), "Polymeric micelles for delivery of poorly water-soluble compounds", Crit. Rev. Ther. Drug Carrier Syst., 20(5), 357-403. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v20.i5.20
  64. Kumar, R., Ray, P.C., Datta, D., Bansal, G.P., Angov, E. and Kumar, N. (2015), "Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles", Vaccine, 33(39), 5064-5071. DOI: 10.1016/j.vaccine.2015.08.025
  65. Labhasetwar, V., Song, C., Humphrey, W., Shebuski, R. and Levy, R.J. (1998), "Arterial uptake of biodegradable nanoparticles: Effect of surface modifications", J. Pharm. Sci., 87(10), 1229-1234. https://doi.org/10.1021/js980021f
  66. Lasic, D.D. (1998), "Novel applications of liposomes", Trends Biotechnol., 16(7), 307-321. https://doi.org/10.1016/S0167-7799(98)01220-7
  67. Le Buanec, H., Vetu, C., Lachgar, A., Benoit, M.A., Gillard, J., Paturance, S., Aucouturier, J., Gane, V., Zagury, D. and Bizzini, B. (2001), "Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes", Biomed. Pharmacother, 55(6), 316-320. https://doi.org/10.1016/S0753-3322(01)00073-7
  68. Le Buanec, H., Vetu, C., Lachgar, A., Benoit, M.A., Gillard, J., Paturance, S., Aucoututier, J., Gane, V., Zaguri, D., Miyake, A., Akagi, T., Enose, Y., Ueno, M., Kawamura, M., Horiuchi, R., Hiraishi, R., Adachi, M., Srizawa, T., Narayan, O., Akshi, M., Baba, M. and Hayami, M. (2004), "Induction of HIVspecific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques", J. Med. Virol., 73(3), 368-377. https://doi.org/10.1002/jmv.20100
  69. Merisko-Liversidge, E.M. and Liversidge, G.G. (2008), "Drug nanoparticles: Formulating poorly watersoluble compounds", Toxicol. Pathol., 36(1), 43-48. https://doi.org/10.1177/0192623307310946
  70. Merisko-Liversidge, E., Liversidge, G.G. and Cooper, E.R. (2003), "Nanosizing: A formulation approach for poorly-water-soluble compounds", Eur. J. Pharm. Sci., 18(2), 113-120. https://doi.org/10.1016/S0928-0987(02)00251-8
  71. Moghimi, S.M. and Hunter, A.C. (2000), "Poloxamers and poloxamines in nanoparticle engineering and experimental medicine", Trends Biotechnol., 18(10), 412-420. https://doi.org/10.1016/S0167-7799(00)01485-2
  72. Moghimi, S.M., Hunter, A.C. and Murray, J.C. (2001), "Long-circulating and target-specific nanoparticles: Theory to practice", Pharmacol. Rev., 53(2), 283-318.
  73. Moghimi, S.M. and Szebeni, J. (2003), "Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties", Prog. Lipid Res., 42(6), 463-478. https://doi.org/10.1016/S0163-7827(03)00033-X
  74. Molento, M.B. (2009), "Parasite control in the age of drug resistance and changing agricultural practices", Vet Parasitol, 163(3), 229-334. https://doi.org/10.1016/j.vetpar.2009.06.007
  75. Moschwitzer, J.P. (2013), "Drug nanocrystals in the commercial pharmaceutical development process", Int. J. Pharmaceutics, 453(1), 142-156. https://doi.org/10.1016/j.ijpharm.2012.09.034
  76. Mozarafi, M.R. (2005), "Liposomes: An overview of manufacturing techniques", Cell. Mol. Biol. Lett., 10, 711-719.
  77. Muller, T. (2001), "Identification of plant-associated enterococci", J. Appl. Microbiol., 91(2), 268-278 https://doi.org/10.1046/j.1365-2672.2001.01373.x
  78. Muller, R.H., Radtke, M. and Wissing, S.A. (2002), "Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations", Adv. Drug Deliv. Rev., 54, S131-S155. https://doi.org/10.1016/S0169-409X(02)00118-7
  79. Munn, L.L. (2003), "Aberrant vascular architecture in tumours and its importance in drug-based therapies", Drug Discov. Today, 8(9), 396-403. https://doi.org/10.1016/S1359-6446(03)02686-2
  80. Murillo, M., Gamazo, C., Irache, J.M. and GoNi, M.M. (2002), "Polyester microparticles as a vaccine delivery system for brucellosis: Influence of the polymer on release, phagocytosis and toxicity", J. Drug Target., 10(3), 211-219. https://doi.org/10.1080/10611860290022642
  81. Nagpal, K., Singh, S.K. and Mishra, D.N. (2016), "Chitosan nanoparticles: A promising system in novel drug delivery", Chem. Pharm. Bull. (Tokyo), 58(11), 1423-1430. https://doi.org/10.1248/cpb.58.1423
  82. Nahar, M. and Jain, N.K. (2009), "Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles", Pharm. Res., 26, 2588-2598. https://doi.org/10.1007/s11095-009-9973-4
  83. Nayak, B., Panda, A.K., Ray, P. and Ray, A.R. (2009), "Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination", J. Microencapsul., 26(2), 154-165. https://doi.org/10.1080/02652040802211709
  84. Nechaeva, E.A., Varaksin, N., Ryabicheva, T., Smolina, M., Kolokoltsova, T., Vilesov, A., Aksenova, N., Stankevich, R. and Isidorov, R. (2001), "Approaches to development of microencapsulated form of the live measles vaccine", Ann. N. Y. Acad. Sci., 944, 180-186.
  85. Nechaeva, E. (2002), "Development of oral microencapsulated forms for delivering viral vaccines", Exp. Rev. Vaccines, 1(3), 385-397. https://doi.org/10.1586/14760584.1.3.385
  86. Niwa, T., Takeuchi, H., Hino, T., Kunou, N. and Kawashima, Y. (1993), "Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with dl-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behaviour", J. Controlled Release, 25(1-2), 89-98. https://doi.org/10.1016/0168-3659(93)90097-O
  87. Noguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T. and Maeda, H. (1998), "Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues", Jpn. J. Cancer Res., 89(3), 307-314. https://doi.org/10.1111/j.1349-7006.1998.tb00563.x
  88. Noyes, A.A. and Whitney, W.R. (1897), "The rate of solution of solid substances in their own solutions", J. Am. Chem. Soc., 19(12), 930-934. https://doi.org/10.1021/ja02086a003
  89. Lipinski, C.A. (2002), "Single-mode compound retrieval for QSAR, QSPR data sets, and batch mode exact structure searching", J. Pharm. Sci., 91(12), 2470-2472. https://doi.org/10.1002/jps.10260
  90. Ojer, P., Salman, H., Da Costa Martins, R., Calvo, J., Lopez de Cerain, A., Gamazo, C., Lavandera, J.L. and Irache, J.M. (2010), "Spray-drying of poly(anhydride) nanoparticles for drug/antigen delivery", J. Drug Deliv. Sci. Technol., 20(5), 353-359. https://doi.org/10.1016/S1773-2247(10)50059-5
  91. Oowaki, H., Matsuda, S., Sakai, N., Ohta, T., Iwata, H., Sadato, A., Taki, W., Hashimoto, N. and Ikada, Y. (2000), "Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery", Drug Deliv Transl Res., 21(10), 1039-1046. URL: http://link.springer.com/article/10.1007%2Fs13346-016-0290-2
  92. Paleos, C.M., Sideratou, Z., Kontoyianni, C. and Drossopoulou, G.I. (2010), "Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system", Bioorg. Med. Chem. Lett., 20(22), 6513-6517. https://doi.org/10.1016/j.bmcl.2010.09.058
  93. Ringsdorf, H. (1975), "Structure and properties of pharmacologically active polymers", J. Polym. Sci., C Polym. Symp., 51(1), 135-153.
  94. Sakthivel, T. and Florence, A.T. (2003), "Adsorption of amphipathic dendrons on polystyrene nanoparticles", Int. J. Pharm., 254(1), 23-26. https://doi.org/10.1016/S0378-5173(02)00671-3
  95. Santhoshkumar, T., Rahuman, A.A., Bagavan, A., Marimuthu, S., Jayaseelan, C., Kirthi, A.V., Kamaraj, C., Rajakumar, G., Zahir, A.A., Elango, G., Velayutham, K., Iyappan, M., Siva, C., Karthik, L. and Rao, K.V. (2012), "Evaluation of stem aqueous extract and synthesized silver nanoparticles using Cissus quadrangularis against Hippobosca maculata and Rhipicephalus (Boophilus) microplus", Exp Parasitol., 132(2), 156-165. https://doi.org/10.1016/j.exppara.2012.06.009
  96. Santos-Magalhães, N.S. and Morsqueira, V.C. (2010), "Nanotechnology applied to the treatment of malaria", Adv. Drug Deliv. Rev., 62(4-5), 560-575. https://doi.org/10.1016/j.addr.2009.11.024
  97. Storni, T., Kundig, T.M., Senti, G. and Johansen, P. (2005), "Immunity in response to particulate antigendelivery systems", Adv. Drug Deliv. Rev., 57(3), 333-355 https://doi.org/10.1016/j.addr.2004.09.008
  98. Sun, L., Zhang, S., Sun, X. and He, X. (2010), "Effect of the geometry of the anodized titania nanotube array on the performance of dye-sensitized solar cells", J. Nanosci. Nanotechnol., 10(7), 4551-4561. https://doi.org/10.1166/jnn.2010.1695
  99. Svenson, S. and Tomalia, D.A. (2005), "Dendrimers in biomedical applications--reflections on the field", Adv. Drug Deliv. Rev., 57(15), 2106-2129. https://doi.org/10.1016/j.addr.2005.09.018
  100. Thakkar, A., Chenreddy, S., Thio, A., Khamas, W., Wang, J. and Prabhu, S. (2016), "Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice", Int. J. Nanomedicine, 11, 3265-3276. https://doi.org/10.2147/IJN.S106736
  101. Tros de Ilarduya, C., Sun, Y. and Duzgunes, N. (2010), "Gene delivery by lipoplexes and polyplexes", Eur. J. Pharm. Sci., 40(3), 159-170. https://doi.org/10.1016/j.ejps.2010.03.019
  102. Waknine-Grinberg, J.H., Even-Chen, S., Avichzer, J., Turjeman, K., Bentura-Marciano, A., Haynes, R.K., Weiss, L., Allon, N., Ovadia, H., Golenser, J. and Barenholz, Y. (2013), "Glucocorticosteroids in nanosterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria", PLoS One, 8(8), e72722. https://doi.org/10.1371/journal.pone.0072722
  103. Zhou, X., Li, Q., Yin, Y., Chen, Y. and Lin, J. (2008), "Identification of medicinal Ganoderma species based on PCR with specific primers and PCR-RFLP", Planta Med., 74(2), 197-200. https://doi.org/10.1055/s-2008-1034289
  104. Zolle, I., Hossain, F., Rhodes, B.A. and Wagner, H.N., Jr. (1970), "Human serum albumin millimicrospheres for studies of the reticuloendothelial system", J. Nucl. Med., 11, 379-380.